Company intelligence / Profile preview

Tanawisa Company Ltd.

likely Bangkok or another major city, Thailandtanawisa.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Tanawisa produces TSO® (Trichuris suis ova), a helminthic probiotic supplement approved by the Thai FDA since 2006. Clinical studies have shown significant improvements in inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis. However, large-scale Phase II trials for Crohn's disease did not meet endpoints, which slowed further pharmaceutical development. The product remains available as a regulated supplement in some markets.

Therapeutic areas
PulmonologyEndocrinologyImmunologyPsychiatryGastroenterologyNeurology
Modalities
Helminthic therapy (Trichuris suis ova, TSO®)Probiotic supplement (biological organism-based)
Industry
Biotech
02

Drug pipeline

1 asset

TSO

Commercial
Indications
Ulcerative colitis, Crohn's disease, Multiple sclerosis, Type 1 diabetes, Asthma, Rheumatoid arthritis, Autism, Lupus, Allergies
03

Partnerships

Ovamed GmbH (historical partnership for GMP production of TSO®, now defunct)Collaborations with University of Iowa researchers during early development phaseProduct supplied to international research groups and clinical trial sponsors including Dr. Falk Pharma and Fortress Biotech/Coronado Biosciences during past clinical studies

Beyond the preview

Go deeper on Tanawisa Company Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tanawisa Company Ltd..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call